Folgen
Mark Clendenning
Mark Clendenning
Bestätigte E-Mail-Adresse bei unimelb.edu.au - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Feasibility of screening for Lynch syndrome among patients with colorectal cancer
H Hampel, WL Frankel, E Martin, M Arnold, K Khanduja, P Kuebler, ...
Journal of Clinical Oncology 26 (35), 5783, 2008
10432008
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
H Hampel, W Frankel, J Panescu, J Lockman, K Sotamaa, D Fix, ...
Cancer research 66 (15), 7810-7817, 2006
6952006
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
L Senter, M Clendenning, K Sotamaa, H Hampel, J Green, JD Potter, ...
Gastroenterology 135 (2), 419-428. e1, 2008
6382008
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt, K Akagi, ...
Nature genetics 46 (2), 107-115, 2014
4862014
Prevalence and penetrance of major genes and polygenes for colorectal cancer
AK Win, MA Jenkins, JG Dowty, AC Antoniou, A Lee, GG Giles, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (3), 404-412, 2017
4342017
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study
AK Win, JP Young, NM Lindor, KM Tucker, DJ Ahnen, GP Young, ...
Journal of clinical oncology 30 (9), 958, 2012
3842012
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics
K Lagerstedt Robinson, T Liu, J Vandrovcova, B Halvarsson, ...
Journal of the National Cancer Institute 99 (4), 291-299, 2007
2972007
Cancer Risks for MLH1 and MSH2 Mutation Carriers
JG Dowty, AK Win, DD Buchanan, NM Lindor, FA Macrae, M Clendenning, ...
Human mutation 34 (3), 490-497, 2013
2742013
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome
AK Win, NM Lindor, JP Young, FA Macrae, GP Young, E Williamson, ...
Journal of the National Cancer Institute 104 (18), 1363-1372, 2012
2552012
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for …
DD Buchanan, YY Tan, MD Walsh, M Clendenning, AM Metcalf, ...
Journal of Clinical Oncology 32 (2), 90, 2014
2432014
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ...
Annals of Oncology 28 (5), 1023-1031, 2017
2262017
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer
AK Win, JG Dowty, SP Cleary, H Kim, DD Buchanan, JP Young, ...
Gastroenterology 146 (5), 1208-1211. e5, 2014
2212014
Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype
MD Walsh, M Clendenning, E Williamson, SA Pearson, RJ Walters, ...
Modern Pathology 26 (12), 1642-1656, 2013
2192013
Identification of nine new susceptibility loci for endometrial cancer
TA O’mara, DM Glubb, F Amant, D Annibali, K Ashton, J Attia, PL Auer, ...
Nature communications 9 (1), 3166, 2018
1992018
Cancer risks for PMS2-associated Lynch syndrome
SW Ten Broeke, HM van der Klift, CMJ Tops, S Aretz, I Bernstein, ...
Journal of Clinical Oncology 36 (29), 2961, 2018
1872018
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
C Rosty, JP Young, MD Walsh, M Clendenning, RJ Walters, S Pearson, ...
Modern Pathology 26 (6), 825-834, 2013
1662013
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival
C Rosty, JP Young, MD Walsh, M Clendenning, K Sanderson, RJ Walters, ...
PloS one 8 (6), e65479, 2013
1642013
Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype
JE Grolleman, RM De Voer, FA Elsayed, M Nielsen, RDA Weren, C Palles, ...
Cancer cell 35 (2), 256-266. e5, 2019
1572019
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome
CW Toon, MD Walsh, A Chou, D Capper, A Clarkson, L Sioson, S Clarke, ...
The American journal of surgical pathology 37 (10), 1592-1602, 2013
1472013
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH
AK Win, JC Reece, JG Dowty, DD Buchanan, M Clendenning, C Rosty, ...
International journal of cancer 139 (7), 1557-1563, 2016
1462016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20